BCG-medac subst sèche c solv flac 1 pce

7680699540013 CH-69954 L03AX03 07.16.1.

No images available

Details

Product number
6995401
CPT
-
Packaging group
1
Unit
Set
Composition
Praeparatio cryodesiccata: bacillus Calmette-Guérin (BCG) vivus attenuatum (RIVM) 0.2 - 3 Mia CFU, polygelinum, glucosum, polysorbatum 80, pro vitro. Solvens: natrii chloridum, aqua ad iniectabile ad solutionem pro 50 ml.

Articles (1)

BCG-medac, poudre et solvant pour suspension intravésicale
Puder
1
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
11/08/2026
Patient information leaflet
Français
11/08/2026
Patient information leaflet
Italien
11/08/2026
Professional SmPC
Allemand
11/08/2026
Professional SmPC
Français
11/08/2026
Professional SmPC
Italien
11/08/2026

Detailed composition

Substance Quantity Type Category
bacillus Calmette-Guérin (BCG) vivus attenuatum (RIVM)
- Substance Wirkstoff (Principe actif)
natrii chloridum
- Substance HNIDK
polygelinum
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK
glucosum
- Substance HNIDK
polysorbatum 80
- Substance HNIDK

Authorization holder

Labatec Pharma SA

1217 Meyrin

Authorization information

Swissmedic authorization number
69954
Drug name
BCG-medac, poudre et solvant pour suspension intravésicale
Galenic form
PULMIV
ATC Code
L03AX03
Authorization status
Z
Dispensation category
A
First authorization
05/03/2026
Authorization expiration date
04/03/2031
IT number
07.16.1.
Domain
Human medicine
Field of application
Behandlung nicht-invasiver urothelialer Harnblasenkarzinome

Packaging details

Description (FR)
BCG-medac subst sèche c solv flac 1 pce
Description (DE)
BCG-medac Trockensub c Solv Durchstf 1 Stk
Market launch
21/09/2026
Narcotic (BTM)
No

Other packaging sizes

Buy us a coffee Explore the data